22nd Century Net Income 2012-2025 | XXII

22nd Century net income from 2012 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
22nd Century Annual Net Income
(Millions of US $)
2024 $-25
2023 $-151
2022 $-60
2021 $-33
2020 $-20
2019 $-27
2018 $-8
2017 $-13
2016 $-12
2015 $-11
2014 $-16
2013 $-26
2012 $-7
2011 $-1
22nd Century Quarterly Net Income
(Millions of US $)
2025-09-30 $5
2025-06-30 $-3
2025-03-31 $-4
2024-12-31 $-7
2024-09-30 $-7
2024-06-30 $-2
2024-03-31 $-9
2023-12-31 $-38
2023-09-30 $-73
2023-06-30 $-21
2023-03-31 $-18
2022-12-31 $-26
2022-09-30 $-13
2022-06-30 $-11
2022-03-31 $-9
2021-12-31 $-14
2021-09-30 $-9
2021-06-30 $-4
2021-03-31 $-5
2020-12-31 $-6
2020-09-30 $-4
2020-06-30 $-5
2020-03-31 $-4
2019-12-31 $-6
2019-09-30 $-10
2019-06-30 $-8
2019-03-31 $-2
2018-12-31 $-9
2018-09-30 $6
2018-06-30 $-7
2018-03-31 $1
2017-12-31 $-4
2017-09-30 $-3
2017-06-30 $-3
2017-03-31 $-3
2016-12-31 $-3
2016-09-30 $-3
2016-06-30 $-3
2016-03-31 $-3
2015-12-31 $-3
2015-09-30 $-3
2015-06-30 $-1
2015-03-31 $-4
2014-12-31 $-6
2014-09-30 $-3
2014-06-30 $-2
2014-03-31 $-5
2013-12-31 $-8
2013-09-30 $-15
2013-06-30 $0
2013-03-31 $-3
2012-12-31 $-4
2012-09-30 $0
2012-06-30 $0
2012-03-31 $-2
2011-12-31 $1
2011-09-30 $0
2011-06-30 $-1
2011-03-31 $-1
Sector Industry Market Cap Revenue
Consumer Staples Tobacco Products $0.003B $0.024B
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
Stock Name Country Market Cap PE Ratio
Philip Morris (PM) United States $291.893B 24.87
British American Tobacco (BTI) United Kingdom $121.628B 0.00
Altria (MO) United States $112.891B 12.41
JAPAN TOB (JAPAY) Japan $70.917B 21.94
Imperial Tobacco Group (IMBBY) United Kingdom $35.552B 0.00
Turning Point Brands (TPB) United States $2.513B 40.67
Universal (UVV) United States $1.332B 13.74
Ispire Technology (ISPR) United States $0.185B 0.00
Charlie's Holdings (CHUC) United States $0.070B 26.00